NCT05322356View on ClinicalTrials.gov

Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
Prostate Cancer
Interventions
OTHER

Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose Supplementation in the Tumor Volume Guided by the TRINITY® PERINE 3D

Target dose supplement with the TRINITY® PERINE 3D system

Trial Locations (1)

38043

RECRUITING

Isabelle Boudry, Grenoble

Sponsors

Collaborators (1)

Koelis
All Listed Sponsors
collaborator

Clinical Investigation Centre for Innovative Technology Network

NETWORK

collaborator

Koelis

INDUSTRY

lead

University Hospital, Grenoble

OTHER